BioCatalystWatch
PMNWorkspace / PMN / OverviewCompany library
ProMIS Neurosciences Inc. logo

ProMIS Neurosciences Inc.

ProMIS Neurosciences Inc. (PMN)

Website

Price
Market cap
Next catalystExpected Q4 2026PMN310 — PRECISE-AD · Study completionSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

PMN310

Toxic amyloid-beta oligomers

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

PMN310

Toxic amyloid-beta oligomers

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Other pipelines

Toxic misfolded TDP-43

Pathogenic alpha-synuclein

PMN260

Misfolded TDP-43

PreINDP1P2P3FilingApproved
PMN311

Toxic amyloid-beta oligomers

PreINDP1P2P3FilingApproved
PMN440

Pathogenic alpha-synuclein

PreINDP1P2P3FilingApproved
PMN440

Pathogenic alpha-synuclein

PreINDP1P2P3FilingApproved
PMN440

Pathogenic alpha-synuclein

PreINDP1P2P3FilingApproved
PMN411

PreINDP1P2P3FilingApproved
PMN400

Pathogenic alpha-synuclein

PreINDP1P2P3FilingApproved
TDP-43 (Intrabody)

TDP-43

History / paused

PMN310

Toxic amyloid-beta oligomers

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

PMN PR & News

PR & News

PMN SEC archive